| Similar Articles |
|---|
 |
The Motley Fool
October 29, 2007
Brian Lawler |
Medicines Stopping the Bleeding The drugmaker outlines plans to grow its top and bottom lines. Investors, take note.   |
The Motley Fool
July 6, 2007
Brian Lawler |
Medicines Decides Not to Share The Medicines Company reacquires its own drug. Until now, privately held European specialty pharma Nycomed has marketed Angiomax in Europe. Investors, take note. |
The Motley Fool
April 10, 2008
Brian Orelli |
The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company. |
The Motley Fool
March 7, 2008
Brian Lawler |
A Little Too Much Drug Variability Another drugmaker has to recall batches of its compound. |
Chemistry World
November 23, 2009
Phil Taylor |
Pharma group aims to banish contaminated ingredients An international consortium aiming to tighten security in the pharmaceutical supply chain and avoid contaminated ingredients finding their way into medicines had its European debut this month. |
Chemistry World
June 21, 2010
Sarah Houlton |
Recalling pharma Recent drug withdrawals and manufacturing failures have highlighted the importance of ensuring that the medicines patients take contain what it says on the label. |
Pharmaceutical Executive
April 1, 2012
Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
Chemistry World
March 17, 2014
Phillip Broadwith |
UK to fast-track access to critical medicines Critically ill patients in the UK could receive new medicines before they are formally approved under a new scheme beginning in April. |
The Motley Fool
February 21, 2008
Brian Lawler |
A Bit of Irony From the FDA The agency has a mixed message on drug importation, as evidenced in the recent possible contamination of China-produced Heparin. |
Chemistry World
August 19, 2008
Ananyo Bhattacharya |
Flask synthesis promises untainted heparin US researchers have created milligrams of pure heparin using enzymes and chemicals - a practical laboratory synthesis that could avoid the contamination issues surrounding the blood-thinning drug |
The Motley Fool
October 25, 2006
Brian Lawler |
The Medicines Company's Heartening Results At today's share price, investors are almost getting the upside associated with TMC's developmental drug pipeline for free, when combined with the sales growth and expanded opportunities available with Angiomax. That should be a hard deal to pass up for patient investors. |
The Motley Fool
February 29, 2008
Brian Orelli |
Bigger Recall, No Big Deal Baxter increases its recall of heparin, but investors shouldn't be that worried. |
Pharmaceutical Executive
November 1, 2012
Lauri Mitchell |
Who Pays for Specialty Medicines? Providers and patients fish for that delicate balance between access and abandonment. |
Chemistry World
August 7, 2015
Suzanne Howson |
Simple probe for heparin quality control Scientists in China have developed a fluorescent probe to detect both heparin and its major contaminant. The sensor could make it easier to monitor the quality of heparin supplies. |
The Motley Fool
April 18, 2008
Brian Orelli |
Recalls Can't Beat Baxter In spite of charges for two recalls, Baxter posts a decent quarter. |
Chemistry World
December 20, 2013
Patrick Walter |
Chinese police seize 222m pounds of fake drugs Counterfeit medicines and raw materials worth more than Yuan2.2 billion have been seized by Chinese authorities. |
Chemistry World
June 23, 2010
Sarah Houlton |
A smaller future for big pharma? Cutting the amount spent on medicines may be an easy way for governments to help balance the books in the short term, but in the long run it will impact the ability to discover new medicines. |
Pharmaceutical Executive
December 1, 2011
William Looney |
2011: End of the Beginning The gap in perception is one of industry's biggest problems because it adds ballast to the idea that medicines are just a simple procurement item. |
Pharmaceutical Executive
December 1, 2010 |
The Sum of All His Parts: Career Reflections of Europe's Chief Drug Regulator The European Medicines Agency is a unique institution, pursuing a mandate shared with a complex web of national and regional groups, each able to place a distinctive imprint around the delicate task of certifying the safety and efficacy of new drugs. |
Chemistry World
October 1, 2012
Andrew Turley |
Pharma should 'double output by 2022' The President's Council of Advisors on Science and Technology advises that pharmaceutical companies should set a goal of doubling output of 'innovative new medicines that meet critical public health needs' over the next 10 -- 15 years. |
Pharmaceutical Executive
November 1, 2006
Sarah Houlton |
Global Report: 'Bout Time The European Union has been late to enter the fight against counterfeiting. Fed up, Parliament has passed a proposal designed to give its countries the nudge they need. |
Chemistry World
March 18, 2013
Andrew Turley |
Interpol teams up with pharma International police service Interpol is teaming up with 29 drug companies to combat the trade in fake medicines. |
Health
July 2007
Curt Pesmen |
Surgery to Avoid #3: Angioplasty A new study has found that heart medication is just as effective as this invasive surgery. |
American Family Physician
December 1, 2005 |
Tuberculosis: What You Should Know A patient hand-out on the disease, who is susceptible, its treatment and medication recommendation. |
Chemistry World
June 2007
Derek Lowe |
Opinion: In the Pipeline A medicinal chemist experienced in pre-clinical drug discovery sets the record straight about pharmaceutical patents on traditional medicines. |
